RecruitingNCT06987825

Chinese Atrial Fibrillation Registry


Sponsor

Beijing Anzhen Hospital

Enrollment

100,000 participants

Start Date

Aug 1, 2011

Study Type

OBSERVATIONAL

Conditions

Summary

This prospective, observational cohort study aims to establish a long-term registry of adult patients with atrial fibrillation (AF) in China to comprehensively characterize patient profiles and evaluate real-world management and outcomes over time. The objectives of the study are to: * Describe the demographic, clinical, and treatment characteristics of AF patients across different stages of disease progression. * Assess the effectiveness and safety of various AF treatment strategies, including oral anticoagulation, catheter ablation, and left atrial appendage closure, in routine clinical practice. * Identify patient- and treatment-related factors that influence therapeutic outcomes. * Explore the role of advanced technologies and artificial intelligence in improving procedural performance, risk stratification, and clinical decision-making in AF care. Participants will undergo standardized baseline evaluation and longitudinal follow-up to collect data on heart rhythm monitoring, treatment exposures, healthcare utilization, clinical events, and patient-reported outcomes. This cohort will generate real-world evidence to inform personalized and evidence-based management of AF.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age ≥ 18 years;
  • Documented atrial fibrillation episode lasting \>30 seconds confirmed by electrocardiogram (ECG), Holter monitor, implantable cardiac monitor, or wearable ECG device
  • Signed informed consent and willingness to participate in follow-up

Exclusion Criteria2

  • Atrial fibrillation due to a reversible cause (e.g., transient secondary AF)
  • Presence of comorbid conditions associated with an expected life expectancy of less than 1 year

Locations(2)

Beijing Anzhen Hospital

Beijing, Beijing Municipality, China

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06987825


Related Trials